Cellular senescence: a link between cancer and age-related degenerative disease?

[1]  H. Soininen,et al.  Astrocytes in the aging brain express characteristics of senescence‐associated secretory phenotype , 2011, The European journal of neuroscience.

[2]  L. Loeb,et al.  Human cancers express mutator phenotypes: origin, consequences and targeting , 2011, Nature Reviews Cancer.

[3]  J. Campisi,et al.  p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotype , 2011, The EMBO journal.

[4]  P. Marie,et al.  Senescence‐associated intrinsic mechanisms of osteoblast dysfunctions , 2011, Aging cell.

[5]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[6]  J. Campisi,et al.  Four faces of cellular senescence , 2011, The Journal of cell biology.

[7]  J. Campisi.  Cellular senescence: putting the paradoxes in perspective. , 2011, Current opinion in genetics & development.

[8]  M. Blagosklonny.  Cell cycle arrest is not senescence , 2011, Aging.

[9]  J. Campisi,et al.  DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion , 2011, Journal of Cell Science.

[10]  H. Matsubara,et al.  Pathophysiology of vascular calcification: Pivotal role of cellular senescence in vascular smooth muscle cells , 2010, Experimental Gerontology.

[11]  Alessandro Bitto,et al.  Stress-induced senescence in human and rodent astrocytes. , 2010, Experimental cell research.

[12]  M. Jensen,et al.  Fat tissue, aging, and cellular senescence , 2010, Aging cell.

[13]  S. Anton,et al.  Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy , 2010, Ageing Research Reviews.

[14]  A. Nakamura,et al.  Tumors induce complex DNA damage in distant proliferative tissues in vivo , 2010, Proceedings of the National Academy of Sciences.

[15]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[16]  R. Weinberg,et al.  Tumor-host interactions: a far-reaching relationship. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Manolagas.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. , 2010, Endocrine reviews.

[18]  L. Lau,et al.  The Matricellular Protein CCN1/CYR61 Induces Fibroblast Senescence and Restricts Fibrosis in Cutaneous Wound Healing , 2010, Nature Cell Biology.

[19]  J. Campisi,et al.  Inflammatory networks during cellular senescence: causes and consequences. , 2010, Trends in molecular medicine.

[20]  K. Chin,et al.  A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen , 2010, PloS one.

[21]  D. Cleveland,et al.  Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.

[22]  D. Schaffer,et al.  Relative roles of TGF-β1 and Wnt in the systemic regulation and aging of satellite cell responses , 2009, Aging cell.

[23]  J. Honnorat,et al.  Update on paraneoplastic neurological syndromes , 2009, Current opinion in oncology.

[24]  P. Adams.  Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. , 2009, Molecular cell.

[25]  Judith Campisi,et al.  Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network , 2009, Proceedings of the National Academy of Sciences.

[26]  N. Sharpless,et al.  Expression of p16INK4a in peripheral blood T‐cells is a biomarker of human aging , 2009, Aging cell.

[27]  R. Effros,et al.  Immunosenescence: what does it mean to health outcomes in older adults? , 2009, Current opinion in immunology.

[28]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[29]  Gordon J. Lithgow,et al.  MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8 , 2009, Aging.

[30]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[31]  Jan Vijg,et al.  Puzzles, promises and a cure for ageing , 2008, Nature.

[32]  S. Lowe,et al.  Senescence of Activated Stellate Cells Limits Liver Fibrosis , 2008, Cell.

[33]  Jonathan Melamed,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[34]  D. Peeper,et al.  Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.

[35]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[36]  M. Karin,et al.  The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. , 2008, Trends in molecular medicine.

[37]  P. Rosenstiel,et al.  Systematic expression profiling of innate immune genes defines a complex pattern of immunosenescence in peripheral and intestinal leukocytes , 2008, Genes and Immunity.

[38]  Michael R. Green,et al.  Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 , 2008, Cell.

[39]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[40]  C. Keller,et al.  Increased Wnt Signaling During Aging Alters Muscle Stem Cell Fate and Increases Fibrosis , 2007, Science.

[41]  P. Hornsby,et al.  Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.

[42]  Carlos Cordon-Cardo,et al.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2007, Nature.

[43]  Jessie C. Jeyapalan,et al.  Accumulation of senescent cells in mitotic tissue of aging primates , 2007, Mechanisms of Ageing and Development.

[44]  J. Campisi,et al.  Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence* , 2006, Journal of Biological Chemistry.

[45]  Jiri Bartek,et al.  p16INK4A is a robust in vivo biomarker of cellular aging in human skin , 2006, Aging cell.

[46]  M. Bennett,et al.  Vascular smooth muscle cell senescence in atherosclerosis. , 2006, Cardiovascular research.

[47]  S. Morrison,et al.  Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing , 2006, Nature.

[48]  R. DePinho,et al.  Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a , 2006, Nature.

[49]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[50]  G. Peters,et al.  Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.

[51]  R. Bernards,et al.  Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence , 2006, Nature Cell Biology.

[52]  Mitch Leslie,et al.  The age of cancer. , 2006, Science of aging knowledge environment : SAGE KE.

[53]  L. Ferrucci,et al.  Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[54]  P. Nelson,et al.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.

[55]  T. von Zglinicki,et al.  Oxygen free radicals in cell senescence: Are they signal transducers? , 2006, Free radical research.

[56]  D. Kurz,et al.  Cellular senescence in vivo: Its relevance in ageing and cardiovascular disease , 2005, Experimental Gerontology.

[57]  J. Little,et al.  Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. , 2005, Cancer research.

[58]  W. Ershler,et al.  Cancer and ageing: a nexus at several levels , 2005, Nature Reviews Cancer.

[59]  J. Joyce,et al.  Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.

[60]  Goberdhan P Dimri.  What has senescence got to do with cancer? , 2005, Cancer cell.

[61]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[62]  R. Colavitti,et al.  Reactive Oxygen Species as Mediators of Cellular Senescence , 2005, IUBMB life.

[63]  J. Campisi.  Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[64]  I. Weissman,et al.  Rejuvenation of aged progenitor cells by exposure to a young systemic environment , 2005, Nature.

[65]  N. Sharpless,et al.  Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.

[66]  Kimi Yamakoshi,et al.  The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. , 2004, The journal of medical investigation : JMI.

[67]  J. Campisi,et al.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.

[68]  Qin M. Chen,et al.  Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. , 2003, Experimental cell research.

[69]  Masashi Narita,et al.  Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.

[70]  Kristopher J Preacher,et al.  Chronic stress and age-related increases in the proinflammatory cytokine IL-6 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Judith Campisi,et al.  Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.

[72]  J. Hoeijmakers,et al.  Aging and Genome Maintenance: Lessons from the Mouse? , 2003, Science.

[73]  C. Finch,et al.  Evolutionary Medicine: From Dwarf Model Systems to Healthy Centenarians? , 2003, Science.

[74]  I. Roninson.  Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. , 2002, Cancer letters.

[75]  M. Blasco,et al.  Putting the stress on senescence. , 2001, Current opinion in cell biology.

[76]  J. Campisi.  Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.

[77]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[79]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[80]  Goberdhan P Dimri,et al.  Regulation of cellular senescence by p53. , 2001, European journal of biochemistry.

[81]  Steven N. Austad,et al.  Why do we age? , 2000, Nature.

[82]  M J Bissell,et al.  The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.

[83]  J. Gray,et al.  Genome changes and gene expression in human solid tumors. , 2000, Carcinogenesis.

[84]  W. Coleman,et al.  Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. , 1997, Cancer research.

[85]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[86]  R. Weinberg,et al.  When cells get stressed: an integrative view of cellular senescence. , 2004, The Journal of clinical investigation.

[87]  A. Knudson,et al.  Chasing the cancer demon. , 2000, Annual review of genetics.

[88]  S. Melov,et al.  Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. , 1995, Nucleic acids research.

[89]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.